eMed is a real program offering FDA-approved GLP-1 medicines. The first thing to know from eMed weight loss reviews is that the self-pay bill has three parts: $49 screening, $149.99 a month for membership, and medicine from $149.99 a month. Employer plans set their own prices.
Two more things the star ratings won't tell you. You'll need a scale and a weekly check-in. And eMed's 4-star Trustpilot score mixes weight-program accounts with older testing reviews. Here's what we could verify about the bill, the weekly routine, and what the reviews actually say.
RX Index Decision Verdict: eMed is a legitimate program offering FDA-approved medicines, scheduled blood tests, and weekly accountability — but if you're paying on your own, compare its separate care fees and get the full medication quote first.
- Best for: People whose employer offers eMed as a benefit, and cash payers who want included blood tests, a side-effect care kit, and weekly accountability.
- Not ideal for: Cash payers watching every dollar, anyone who wants Zepbound or Foundayo without an employer plan, anyone who needs a clearly documented insurance-billing option, and anyone who won't weigh in every week.
- The factor that matters most: Whether eMed comes through your employer. That changes your price, your medicine choices, and sometimes whether you need eMed to keep your coverage.
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
Jump to: Your employer offers eMed · Already a member and want to cancel · eMed vs. Ro vs. your own doctor
Which eMed are you looking at?
eMed runs two versions of its GLP-1 program. The self-pay version accepts applications from US adults and offers Wegovy, as a daily pill or a weekly pen, after clinical approval. The employer version is a work benefit: your employer sets the price and the medicine list, and some plans include Zepbound and Foundayo.
Think of it like a gym. You can buy a membership yourself at the posted price, or your company can hand you one at its price with its rules. Reviews, prices, and rules from one version don't always apply to the other.
| eMed self-pay | eMed through your employer | |
|---|---|---|
| Who can join | Adults 18 and older, after clinical review (eMed FAQ) | Eligible adults on a participating employer plan (eMed support) |
| Medicines | Wegovy pill or Wegovy pen (eMed FAQ) | Set by your employer. Tulane's announced 2027 benefit lists Wegovy pill and injection, Zepbound, and Foundayo (eMed + Tulane) |
| What you pay | $49 screening; $149.99/month membership; medicine from $149.99/month, charged only if approved (eMed pricing) | Set by the offer. Tulane's announced 2027 benefit lists a $150 copay per prescription. Partner offers include $89.99/month promotional membership at Highway Transport and $119.99/month on an annual subscription at Ingenovis; medication is separate on those two offers. |
| Check-in rule | Weekly check-ins and a scale | The published employer support page sets a 75% completion rule over a rolling three months; check your program's terms (eMed support) |
| Where to start | eMed's individual page | Your HR notice, benefits portal, or the eMed app code your employer gives you |
Highway Transport's $89.99 rate runs through December 31, 2027, then renews at $114.99/month from January 1, 2028; shipping is also separate. Ingenovis calls its offer an annual subscription but does not make the amount due upfront clear in the text we could read. Ask for the payment schedule before joining.
Checked October 23, 2026. This review covers the US. If you're in the UK, eMed's UK weight-loss services run through SheMed and HeMed (eMed UK).
What does eMed cost?
On eMed's self-pay program, screening is $49, membership is $149.99 a month, and medicine starts at $149.99 a month. Medicine is charged only if you're approved. Screening, one membership charge, and the starting medicine charge add to $348.98; that is not a confirmed checkout or first-month total.
The sticker price is not the whole receipt. Our measure, True Monthly Cost, adds up everything you must pay: medicine at your dose, membership, consults, labs, and shipping. Here's what we could verify, piece by piece.
| Charge | Amount | When you pay | Can you get it back? |
|---|---|---|---|
| Screening kit + clinical review | $49 once | Screening stage; confirm the exact charge timing | No, once the kit ships or after your onboarding call |
| Membership | $149.99 a month | eMed's page doesn't say exactly when the first charge hits — ask | Not stated in eMed's public FAQ |
| Medicine | From $149.99 a month | Only if you're approved | No, once it's dispensed |
Sources: eMed pricing and eMed FAQ, checked October 23, 2026.
We couldn't confirm the current higher-dose medicine prices, extra charges, or the date membership billing begins. Ask eMed for those three answers before paying; the copy-and-send questions below cover them.
What does the medicine cost at higher doses?
eMed's current individual page shows only a starting price. Its separate Commitment Program terms, last updated March 11, 2026, list the prices below. They describe that older offer, not a confirmed price schedule for today's standard individual program. Those terms also say medicine bills can include dispensing, shipping, and tax.
| Wegovy form and dose | Older eMed Commitment offer only (Mar 11, 2026 terms) | NovoCare Pharmacy today |
|---|---|---|
| Pill, 1.5 mg (30 tablets) | $149 | $149 |
| Pill, 4 mg | $199 (after April 15, 2026) | $199 |
| Pill, 9 mg or 25 mg | $299 | $299 |
| Pen, 0.25 or 0.5 mg (4 pens, 28 days) | $199 for the first 2 fills, then $349 | $199 for each of the first 2 eligible fills, then $349; see eligibility and deadlines below |
| Pen, 1–2.4 mg | $349 | $349 |
Sources: eMed Commitment Program terms (last updated March 11, 2026); NovoCare Pharmacy Wegovy prices, checked October 23, 2026. eMed's current starting price is $149.99, so ask for today's price at your dose before you pay.
NovoCare's pen discount is for people who have not filled Wegovy injection through NovoCare or NovoCare Legacy. The prescription must be written and received by the pharmacy by December 31, 2026, and shipped by January 31, 2027 (delivery terms).
One small trap: a pill bottle lasts 30 days, but a box of pens lasts 28 days. Thirteen pen fills cover 364 days; 12 pill bottles cover 360 days. Neither is exactly a 365-day year.
How does eMed compare with the same medicine elsewhere?
Ro and NovoCare publish current Wegovy pill prices by dose. eMed's current individual page gives only a starting price, so get its quote before comparing the whole bill. Here's a side-by-side using the Wegovy pill, since that's eMed's headline offer.
| eMed self-pay | Ro, monthly plan | Ro, 12-month prepaid plan | Your own doctor + NovoCare Pharmacy | |
|---|---|---|---|---|
| Screening or introductory care charge | $49 screening (not refundable once shipped or after the onboarding call) | $39 introductory month; published refund if not eligible | $39 introductory month; same refund offer | Your visit cost |
| Listed screening, one care charge and starting medicine charge | $348.98 ($49 + $149.99 + $149.99); not a confirmed first bill | $188 ($39 + $149) | $188 before the later annual prepayment | $149 + visit |
| One $299 pill fill plus the care charge | Current medicine quote needed, plus $149.99 membership | $448 ($149 + $299) | $299 for medicine; care already prepaid | $299 + any visits |
| Care-fee budget example | $1,848.88: kit + 12 membership charges | $1,678: intro + 11 monthly charges, covering 12 membership months | $927: $39 intro + $888 upfront for 12 more months, covering 13 membership months | No membership through this pharmacy route; visits vary |
| Example: 12 pill fills + the care payments above | Full total unconfirmed | $5,016: 360 days of pills + 12 membership months | $4,265: 360 days of pills + 13 membership months | $3,338 for 360 days of pills + visits |
| Medicines offered | Wegovy listed | Wegovy pill and pen, Foundayo, Zepbound KwikPen, Ozempic, Saxenda | Same | Wegovy through this comparison; other medicines need a suitable pharmacy |
| Insurance help | Not described for the individual offer | Free coverage check for Ozempic, Wegovy, and Zepbound autoinjector pens; prior authorization help | Same | Your doctor's office |
| Labs | At-home blood tests at the start, 6 months, and 12 months, included | Lab testing if needed; additional tests may cost extra | Same | Your doctor orders; your plan may cover |
Checked October 23, 2026: eMed pricing, eMed FAQ, Ro pricing, Ro terms, Ro insurance, NovoCare Pharmacy. These are sums of the listed components, not complete quotes; any extra charges still need checking. The medicine and membership periods differ as shown.
How we did the math, so you can check it:
- Example for 12 pill fills: a hypothetical price basket with one fill at $149, one at $199, and ten at $299. At NovoCare's and Ro's published single-fill prices: $149 + $199 + (10 × $299) = $3,338 for 12 bottles, or 360 days.
- eMed care charges: $49 + (12 × $149.99) = $1,848.88 before medicine or other charges. We did not use its older Commitment prices to calculate today's full medicine budget.
- Ro monthly example: $39 + (11 × $149) = $1,678 in membership charges. Add the 12-fill medicine basket: $1,678 + $3,338 = $5,016.
- Ro prepaid example: $39 + $888 = $927 for the introductory month and 12 more membership months. Add the same 12-fill medicine basket: $927 + $3,338 = $4,265. This buys an extra membership month, not an extra bottle of medicine.
- The care-payment gap: eMed's kit plus 12 membership charges is $170.88 more than Ro's 12-month monthly-payment example and $921.88 more than Ro's intro-plus-annual prepayment. Those are differences between the care payments shown, not verified savings on a full year of treatment.
This is a budget example, not a dosing plan. Your clinician decides your dose and when it changes. An unknown fee isn't $0 — if eMed adds shipping or tax, add it in.
The Ro annual option means $888 paid upfront after the $39 introductory month, not $74 charged each month. Its terms say paid membership fees are nonrefundable and cancellation must happen at least 48 hours before renewal to avoid another charge; the initial ineligibility refund is a separate offer.
What do you get for eMed's care fees? Three scheduled at-home blood tests, a side-effect care kit, and weekly accountability built in. Whether those care features are worth the extra fees depends on whether you'd get those labs and that structure anyway.
The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and its drug list (your formulary), whether you want FDA-approved or compounded medicine, a shot or a pill, and your budget. Before you pay eMed's $49, The RX Index's Find My GLP-1 Path tool can show which paths fit you — free, about 2 minutes, no signup.
What do eMed weight loss reviews actually say?
eMed's Trustpilot page shows 4.0 stars from 260 reviews and includes older COVID-testing accounts alongside weight-program reviews. It lists 4 reviews in the last 12 months. The weight-program accounts we read praise a fast kit and flexible blood draw; one raises surprise about the scale and weekly weigh-ins.
That matters because testing and weight-loss care are different services. A testing review can describe a kit or video visit without telling you much about GLP-1 care.
| What we found (October 23, 2026) | What it means for you |
|---|---|
| Trustpilot: 4.0 from 260 reviews, under the name "eMed Labs LLC" | A company-wide score, not a weight-program score |
| 59% five-star and 33% one-star | Most ratings sit at either end of the scale |
| 4 reviews in the last 12 months | Most reviews are older than a year |
| Trustpilot notes the company hasn't recently invited reviews | Trustpilot itself says the reviews may not be representative |
| Apple App Store, "eMed Population Health" (the employer app): 4.2 from 10 ratings | A very small sample |
Sources: Trustpilot eMed profile; Apple App Store.
Here are the recent weight-program reviews we read, in plain words:
- Sandra, Trustpilot, March 3, 2026 (1 star): She ordered the Wegovy starter kit and didn't know she'd need a scale and to send weekly weight photos. She didn't want to buy a scale.
- Jacky Ferro, Trustpilot, December 22, 2025 (5 stars): She first used eMed for COVID testing at work, then joined the weight program and liked the blood test.
- blainecars, Trustpilot, November 13, 2025 (5 stars): The kit came fast, and they finished onboarding and the blood draw at 3 a.m. on their own schedule.
- Happycamper2510, App Store, October 22, 2025 (5 stars): Said the weekly check-ins kept them on track and the app reminded them about their shots.
- Bendyguy, App Store, June 1, 2025 (1 star): Using it through an employer, said the weekly check-in's weight entry and medicine scan didn't work. eMed replied and asked them to contact support.
- Shift Time, App Store, May 7, 2025 (5 stars): Liked the at-home testing and round-the-clock access while working odd shifts.
These are individual stories, not a survey. They tell you what to ask about. They don't tell you whether the medicine will work for you, or whether it's safe for you.
We don't publish a numeric RX Index Score for eMed. GLP-1 Reviews' 4.5 out of 5 is that site's editorial score, not a patient rating.
Is eMed legit?
Yes. eMed is a real company that started with at-home COVID testing in 2020 and now runs GLP-1 programs for individuals and employers. Novo Nordisk, which makes Wegovy, lists eMed among the independent telehealth providers on its NovoCare site, while saying it doesn't endorse any of them.
A few facts worth knowing:
- Who runs it: Linda Yaccarino, the former CEO of X, became eMed's CEO in August 2025 (eMed's announcement). Tom Brady is listed as its Founding Chief Wellness Officer (eMed) and as a co-owner on its healthcare-systems page.
- Who prescribes: eMed says it's not a medical provider. It partners with licensed clinicians who can prescribe in all 50 states (eMed FAQ).
- The NovoCare listing: Novo Nordisk says it gets no referral payments from the listed companies and doesn't vouch for any provider's care (NovoCare). The listing confirms eMed is included; it is not a guarantee of prescribing or care quality.
- Big employer deals: eMed describes its partnership with CVS Caremark on employer GLP-1 access (eMed's employer article).
eMed also says it's "trusted by 50k members" and reports high adherence from its own employer data. Those are company claims. We couldn't independently verify them.
What about the eMed study in the news?
In October 2026, Nature Medicine published a study of 8,127 women in the UK who started GLP-1 treatment through a digital program — 99.8% on tirzepatide (study abstract on PubMed). eMed is the clinical and technology provider for that UK service, SheMed (eMed UK).
It's an observational study with no comparison group, in a different country, mostly on a different medicine than eMed's US self-pay Wegovy offer. The author list includes SheMed and eMed Healthcare UK affiliations. It describes a program delivered to thousands of people; it doesn't show that eMed's US program will produce better results than another provider.
What does eMed ask you to do every week?
eMed's program runs on participation, not just a prescription. You need a scale, a weekly check-in in the app, eMed's own blood kit at the start and again at 6 and 12 months, and a short questionnaire before refills. Employer programs can drop you if you miss too many check-ins.
| When | What eMed asks | Ask yourself |
|---|---|---|
| Before approval | Health profile and eMed's own at-home blood kit; no outside lab results accepted | Am I OK paying $49 before I know if I'm approved? |
| Every week | A check-in under 60 seconds and your weight (you'll need a scale) | Do I own a scale, and will I do this weekly? |
| Every month | A clinical consultation and a refill questionnaire | Who fixes it if the app or a refill gets stuck? |
| 6 and 12 months | Repeat blood test and clinical review | Does the schedule work for me? |
Source: eMed FAQ, checked October 23, 2026.
On some employer plans, the weekly check-in means saying your weight out loud, snapping a photo of the scale, and scanning your medicine (eMed + Tulane). eMed's published employer support page sets a requirement of at least 75% of weekly check-ins over a rolling three months (eMed support). Check your own program's rules.
Some people love this. One App Store reviewer said the check-ins kept them on track. Others feel watched. Neither is wrong — just know which one you are before you pay.
A quick self-check before you spend $49:
- [ ] I'm 18 or older.
- [ ] I own a scale, or I'm willing to buy one.
- [ ] I'll do a one-minute check-in every week.
- [ ] I'll ask which starting or continuation criteria apply to me. (Not sure what BMI means for treatment? See our GLP-1 BMI eligibility chart.)
- [ ] None of the "talk to your own doctor first" situations below apply to me.
Checking every box doesn't mean you'll be approved. A licensed clinician decides after reviewing your health profile and lab results. eMed says it will update you within three business days after that review; a required live appointment can affect the timeline.
Is 24/7 support the same as seeing a doctor anytime?
No. eMed offers round-the-clock screening and side-effect support, but its FAQ says the support team isn't medical staff. You can escalate a side effect to a clinician through the app; that's not the same as an instant doctor visit. For the serious symptoms listed below, get medical help right away rather than waiting for an app reply.
Which medicines can eMed prescribe?
eMed's self-pay FAQ says its clinicians prescribe Wegovy, as a daily pill or a weekly pen. Employer versions can include Zepbound and Foundayo. Its consumer FAQ says it offers only FDA-approved GLP-1 medicines.
| Medicine | How you take it | FDA-approved for weight management? | eMed self-pay | Tulane's announced 2027 benefit |
|---|---|---|---|---|
| Wegovy pill (semaglutide) | Daily tablet | Yes | Yes | Yes |
| Wegovy pen (semaglutide) | Weekly shot | Yes | Yes | Yes |
| Zepbound (tirzepatide) | Weekly shot | Yes | Not listed | Yes |
| Foundayo (orforglipron) | Daily tablet | Yes | Not listed | Yes |
| Compounded GLP-1s | Varies | No — compounded drugs are not FDA-approved | Not offered | Not offered |
Availability sources: eMed FAQ and eMed + Tulane. Approval and form sources: Wegovy label, Zepbound label, Foundayo FDA label, and FDA on unapproved GLP-1s. Checked October 23, 2026. Want the pill-or-shot breakdown? See Wegovy pill vs. injection and our Wegovy pill reviews.
Who should talk to their own doctor first?
Price can't tell you whether a medicine is safe for you. Wegovy's label says not to use it if you or a family member has had medullary thyroid carcinoma (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2) (Wegovy prescribing information). The label also rules it out after a serious allergic reaction to semaglutide or its ingredients.
eMed's published employer-support rules exclude people who are pregnant, trying to get pregnant, or breastfeeding; have type 1 diabetes; have a current or past eating disorder; or have a history of pancreatitis, among other conditions (eMed support). If you're under 18 or any of these fit you, start with your own doctor, not an online program. Our GLP-1 hard contraindications guide and pregnancy and GLP-1s guide can help you prepare.
On any GLP-1: get medical help right away for severe stomach pain that won't go away, or signs of a serious allergic reaction like swelling of the face or throat or trouble breathing.
Does eMed take insurance, HSA, or FSA?
eMed's individual pages publish self-pay prices and don't describe insurance billing. You can try paying with an HSA or FSA card, but eMed says acceptance isn't guaranteed. It will send receipts, a prescription, or a letter of medical necessity so you can ask your plan to pay you back.
These are four separate questions, and people mix them up all the time:
- Does my insurance cover the medicine? That's your plan's call. Confirm whether your exact eMed offer can use that coverage before paying.
- Can I use a manufacturer savings card? Wegovy's commercial copay offer requires eligible commercial coverage; its self-pay offer has different rules (manufacturer terms).
- Will my HSA or FSA card work at checkout? Maybe. eMed doesn't promise it.
- Is it a qualified medical expense? That depends on IRS rules and what the expense treats. Keep records; ask your FSA administrator what proof it needs (IRS Publication 969).
More help: Can I use my HSA for a GLP-1?, Can I use my FSA for a GLP-1?, and how to get a letter of medical necessity.
If you'd rather try insurance first, start with our GLP-1 insurance coverage guide.
What if I have Medicare?
eMed's self-pay pages don't address Medicare. The Medicare GLP-1 Bridge, which runs July 1, 2026 through December 31, 2027, lets eligible people with Part D drug coverage get certain GLP-1s for a $50 copay, after prior authorization (a permission slip your prescriber requests) (CMS). The Bridge runs outside your Part D plan's usual drug benefit and has its own eligibility rules. If the medicine is being prescribed for a use that can be covered under Part D, use that route instead. Your own qualified prescriber can start the appropriate request. Read our Medicare GLP-1 Bridge guide before paying any cash program.
My employer offers eMed. Should I use it?
Start with your employer's eMed offer: its price and coverage rules can differ from self-pay. Some employers now route GLP-1 coverage through eMed, so people already on a GLP-1 may need to enroll to keep coverage. Your HR notice has the dates and costs that apply to you.
Here's one real example: Tulane University's announced 2027 benefit, as described on eMed's page.
| Tulane + eMed detail | What the page says |
|---|---|
| Cost | $150 copay per prescription for Wegovy pill, Wegovy injection, Zepbound, or Foundayo; prices may change if the maker's price changes |
| Paying for copays | Tulane FSA, HRA, and HSA funds can be used; copays don't count toward deductibles |
| Already on a GLP-1? | Register with eMed to continue coverage; registration opens December 1, 2026 |
| Medicine start | Shipping begins January 1, 2027; allow 1–2 weeks for delivery |
| Privacy | Tulane's page says its benefits team gets only group totals, not individual details |
Source: eMed + Tulane, checked October 23, 2026. Your employer's version may differ.
Say you're 48, already on Zepbound through work, and HR says your coverage moves to eMed in January. Register as soon as it opens, upload your current prescription, and ask who covers refills during the switch. Tulane's page says registering early helps avoid a gap. Don't stop your medicine on your own while you wait — ask your current prescriber.
For the organization-sponsored program described on eMed's support page:
- You get 30 days to complete your screening kit, and the blood sample must be back within four days of collection.
- Refills come from a short questionnaire at every third weekly check-in.
- If you're not approved, you can usually be rescreened once a year.
- Help: 1-866-955-1173 or support@emed.com.
Source: eMed support. For the bigger picture, see employer GLP-1 coverage and our employer coverage tracker.
Can you cancel eMed or get a refund?
eMed's FAQ says the $49 blood kit can't be refunded once it ships or after your onboarding call, and medicine can't be returned or refunded once it's dispensed. To cancel or ask about a charge on the self-pay program, contact eMed at 1-800-682-2829 or support@emed.com. We couldn't read eMed's general US terms, so the exact cancellation deadline is unconfirmed.
Before you cancel, do these four things:
- Contact eMed before your next billing date and ask for written confirmation.
- Ask about any medicine order that's already processing. Canceling care may not stop a pharmacy charge.
- Save the confirmation and the date your paid time ends.
- Talk with your clinician before you stop a medicine.
Unused medicine? eMed recommends a pharmacy or community take-back program. If none is available, follow FDA disposal guidance.
Did you sign up for eMed's 12-month "Commitment Program"?
Some members signed up for a separate offer with its own rules. It waived the $149 monthly membership for a year in exchange for monthly refill forms, at least one of four weekly check-ins each month, and blood work at 6 and 12 months. Its enrollment window was scheduled to end February 28, 2026, unless eMed extended it.
If you're in it, these terms matter (Commitment Program terms, last updated March 11, 2026):
- Leaving early without an approved reason triggers a fee the terms describe as "three months of the waived Membership Fees or $417." Three months at $149 is $447, not $417 — so ask eMed to confirm the exact amount in writing.
- The fee can be waived for medical or safety reasons, financial hardship, losing eligibility (like moving), or a medicine price jump of more than 20% over what you were told.
- Medicine is billed separately, including dispensing, shipping, and tax, and isn't refundable once dispensed.
- Stopping medicine does not automatically end the commitment. If your clinician stops treatment, ask eMed to confirm your membership status and whether a medical or safety fee waiver applies.
Already a member and just need help with billing, a refill, or the app? Contact eMed directly: 1-800-682-2829 or support@emed.com for individuals (eMed FAQ), or 1-866-955-1173 for employer programs (eMed support). Deleting your account isn't the same as canceling charges.
eMed vs. Ro vs. your own doctor: which fits you?
eMed and Ro both arrange brand-name GLP-1 care through clinicians, with medicine billed on top of a membership. Ro lists lower care fees, a refund of its $39 if you're not eligible, more medicines, and help with insurance paperwork. eMed includes three scheduled at-home blood tests and a side-effect care kit. Your own doctor plus NovoCare Pharmacy avoids a telehealth membership; visits can still cost money.
| Your situation | Best next step | Keep in mind |
|---|---|---|
| Your employer offers eMed | Check your HR documents and benefit price first | The standard self-pay price may not apply to your offer |
| You want included labs and weekly accountability, and the full bill works | eMed self-pay, using the question list below | A clinician still decides if you're approved |
| You're paying cash and want to compare care fees for the same Wegovy pill | Compare Ro, or your own doctor + NovoCare | Ro's 12-month plan is $888 paid upfront after the $39 intro month |
| You want Zepbound or Foundayo without an employer plan | Ro lists both; eMed self-pay lists Wegovy only | Prices differ by dose |
| You have commercial insurance that might cover a pen | Ro's free coverage check | It checks select pens; coverage is your insurer's decision |
| You already have a doctor who'll prescribe | Ask about NovoCare Pharmacy self-pay (our guide) | Doctor visits can still cost money |
| You have Medicare Part D | Ask your prescriber about Part D coverage or the Medicare GLP-1 Bridge | The Bridge has its own plan and clinical rules; prior authorization is required |
| You're not sure | Find My GLP-1 Path (linked above) | It suggests paths; it doesn't check your coverage |
Here's the honest trade-off with Ro. It includes lab testing when needed, but its published offer does not promise eMed's fixed three-test schedule or a side-effect care kit. If those features matter most, eMed is worth considering. Ro's listed care fees are lower, and its insurance team can submit prior authorization paperwork for eligible medicines if your plan needs it (Ro pricing, Ro insurance). Get eMed's current medication quote before comparing the whole bill.
If you're paying cash for a brand-name pill or pen, or want help with insurance paperwork, compare Ro's plans. It starts at $39 for the first month — refunded if you're not eligible — then $149 a month, or $888 upfront for the next 12 months ($74/month equivalent). Medicine is billed separately; the upfront membership payment is nonrefundable under Ro's terms.
See Ro's pricing and insurance options (sponsored affiliate link, opens in a new tab)
If eMed's built-in blood tests and weekly check-ins are exactly what you want, review eMed's current individual offer — and send these questions first.
Copy and send this to eMed before you pay the $49:
Before I enroll, please confirm in writing: which eMed offer and terms apply to me; the total charged today; when my $149.99 membership starts billing, how often, and any minimum term or renewal rules; the price for each Wegovy dose I could be prescribed and how many days each fill covers; any shipping, dispensing, or tax charges; what's refunded if I'm not approved or my clinician stops treatment; the weekly check-in rules; and the exact steps and deadline to cancel membership and future medicine orders.
What we actually verified
Checked October 23, 2026: eMed's individual pricing page and FAQ; its employer support page; its Tulane, Highway Transport, and Ingenovis pages; its Commitment Program terms (last updated March 11, 2026); eMed UK; NovoCare's provider list, Wegovy prices, and savings terms; Ro's pricing, terms, free checker, and insurance pages; CMS's Medicare GLP-1 Bridge information; current medicine labels and FDA sources listed above; IRS Publication 969; and eMed's Trustpilot and App Store records. For the UK study, we checked the PubMed record and abstract; we did not review the full methods.
eMed says, not tested by us: its care features, blood-test markers, the update within three business days after clinician review, its clinician network, 24/7 support, and its member and adherence figures.
Our own work: the program comparison, the cost tables, every calculation, and the selected review breakdown.
What we couldn't confirm: eMed's current per-dose prices beyond the advertised starting price, whether it adds shipping or tax, when membership billing starts, eMed's general US terms and checkout details (including the cancellation deadline, renewal rules, and minimum commitment), and whether the Commitment Program is still open. We didn't sign up, take any medicine, or test eMed's support.
Our methodology weighs six factors: clinical legitimacy and safety (25%), care and support model (20%), medication options and fit (15%), transparency and honest terms (15%), value / true cost (15%), and access and speed (10%). We haven't published a numeric score for eMed, so this review uses our Decision Verdict.
eMed weight loss reviews: common questions
Do I need a scale for eMed?
Yes. eMed's FAQ says you'll verify your weight at sign-up and check in weekly. On some employer plans, the weekly check-in includes a photo of the scale. If weekly weighing would upset you, that's worth knowing before you pay.
Will the weekly check-ins fit my schedule?
eMed says check-ins take under a minute and are open 24/7, and reviewers have finished onboarding at odd hours. The published employer support page sets a 75% completion rule over a rolling three months; confirm your own program's rule. One App Store reviewer reported the check-in tools not working on their phone, so ask support how app problems get fixed.
Is the $49 refundable if I'm not approved?
eMed's FAQ says the kit can't be refunded once it ships or after your onboarding call. The medicine is charged only if you're approved. Ask in writing what else, if anything, comes back if you're turned down.
Is the medicine included in the $149.99 membership?
No. Membership and medicine are separate charges. The self-pay page lists $149.99 a month for membership plus medicine from $149.99 a month and a separate $49 screening fee. Those three charges add to $348.98, but the amount due at checkout and full first-month bill are unconfirmed.
Can I use blood work I already have?
For the individual program, no: eMed requires its own at-home kit and doesn't accept outside lab results. Its schedule includes repeat kits at 6 and 12 months.
Does eMed prescribe Zepbound?
The current individual FAQ names Wegovy and does not list Zepbound. Some employer versions include Zepbound and Foundayo. If you want Zepbound and pay cash, compare programs that list it.
I'm already on a GLP-1 and my employer is switching to eMed. What happens?
On Tulane's version, current users register early, upload their current prescription, and a clinician reviews it; registration opens December 1, 2026. Your employer's dates and rules may differ, and a lower current BMI does not settle whether ongoing treatment will be approved. Ask HR and eMed for continuation criteria and who handles refills during the switch; don't stop your medicine without talking to your prescriber.
Does eMed take insurance or HSA/FSA?
The individual pages publish self-pay prices and don't describe insurance billing. You can try an HSA or FSA card, but eMed says acceptance isn't guaranteed; it can send paperwork for a reimbursement request. Employer versions follow your employer's rules.
How do I cancel eMed?
For the self-pay program, contact eMed at 1-800-682-2829 or support@emed.com before your next charge, and get written confirmation. Shipped kits and dispensed medicine aren't refundable. If you joined the 12-month Commitment Program, an early-exit fee may apply unless you qualify for a waiver.
Is eMed Tom Brady's company?
He is a co-owner, according to eMed's healthcare-systems page, and serves as Chief Wellness Officer. Linda Yaccarino, the former CEO of X, became CEO in August 2025.
Is eMed the same as SheMed?
They're connected but not the same. eMed is the clinical and technology provider behind SheMed and HeMed in the UK. If you're in the US, eMed's US program and reviews are the ones that apply to you.
Sources
Sources checked October 23, 2026. Dates beside individual entries identify publication or policy updates.
- eMed, GLP-1 program pricing (individuals)
- eMed, FAQ, including refunds
- eMed, Employer program support and FAQ
- eMed, Commitment Program terms — last updated March 11, 2026
- eMed, Tulane University program
- eMed, partner pages: Highway Transport, Ingenovis
- eMed, About and eMed UK
- NovoCare, Find a doctor (telehealth providers) and Wegovy pharmacy prices
- Novo Nordisk, Wegovy prescribing information
- CMS, Medicare GLP-1 Bridge — page modified July 13, 2026
- Ro, Weight loss pricing and Insurance
- Trustpilot, eMed Labs LLC reviews
- Apple App Store, eMed Population Health
- Deanfield J, et al., Real-world, digital-first delivery of GLP-1 receptor agonist therapy in women, Nature Medicine — published October 16, 2026
- eMed, Linda Yaccarino appointment announcement — August 5, 2025
- Abbott, At-home COVID-testing partnership with eMed — December 16, 2020
- eMed, Healthcare-systems page identifying Tom Brady as co-owner and employer article describing the CVS Caremark partnership
- Ro, Membership terms — revised April 2, 2026; free insurance checker
- NovoCare, Wegovy savings terms and delivery terms
- Eli Lilly, Zepbound prescribing information; FDA, Foundayo prescribing information
- FDA, Concerns about unapproved GLP-1 drugs and unused-medicine disposal
- IRS, Publication 969, 2025 edition; medical-expense FAQ
- CMS, Medicare GLP-1 Bridge information for providers
- PubMed, UK study record and abstract
Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.